Leading Patent Attorney David Dykeman discusses how medtech funding is at an all-time high, so optimizing your company’s patent portfolio is paramount. Patents are the new currency! In addition, intellectual property (IP) are the keys to the castle and must secure and control it across global partnerships, collaboration and change.
How a Strategic Patent Portfolio and Secure IP Help MedTech Companies Grow
This podcast brings together thought leaders from the health and life science industry talking about compliance, quality and product success in medical devices. Hosts: Chuck Serrin, VP Industry Marketing, Medical Device & Life Sciences, and Rachel Jang, Partner Enablement Manager, at Propel.
Look out for an email from us.